Sava Infond’s Exact Sciences EXAS Stock Holding History

Sava Infond’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,250	Closed	-$432K	–	232
2025 Q4	$432K	Sell	4,250 -1,000	-19%	-$80.3K	0.06%	137
2025 Q3	$287K	Sell	5,250 -900	-15%	-$45K	0.04%	150
2025 Q2	$327K	Hold	6,150	–	–	0.05%	140
2025 Q1	$266K	Hold	6,150	–	–	0.05%	147
2024 Q4	$346K	Buy	+6,150	New	+$383K	0.06%	138

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Sava Infond's EXAS Position: Q1 2026 in Review

Sava Infond sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,250 shares — an estimated $432K sold.

Sava Infond first reported a position in EXAS in Q4 2024 and held it in 5 quarters. The position peaked at $432K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Sava Infond reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Sava Infond sold 4,250 Exact Sciences shares in Q1 2026, an estimated $432K.
Sava Infond first reported a position in Exact Sciences in Q4 2024 and held it in 5 quarters.
Sava Infond's Exact Sciences position peaked at $432K in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Sava Infond's 13F filing for Q1 2026, filed 11 May 2026.